北京大学肿瘤医院

What 北京大学肿瘤医院 does

Peking University Cancer Hospital (北京大学肿瘤医院) is a National Class III Grade A specialized cancer hospital founded in 1976 and affiliated with Peking University, operating under the Beijing Municipal Health Commission. The hospital delivers end-to-end oncology services spanning prevention, screening, diagnosis, treatment, and rehabilitation, organized around specialty centers including Gastrointestinal Oncology, Thoracic Oncology, Breast Cancer Prevention and Treatment, Soft Tissue and Retroperitoneal Tumors, and Molecular Diagnostics, integrated through a Multi-Disciplinary Treatment (MDT) model.

Its technology stack spans single-cell spatial transcriptomics, multi-omics analysis (genomic, transcriptomic, proteomic), patient-derived tumor cell cluster models, AI-assisted diagnostic and surgical planning systems, molecular diagnostics with high-throughput sequencing, precision radiotherapy, and interventional endoscopy. Research is anchored by national-level key laboratories in cancer etiology, molecular oncology, and GI translational research, led by two Chinese Academy of Engineering academicians (Ji Jiafu and Zhan Qimin), and has produced 23 national/international clinical guidelines (including China's first gastric cancer guideline), 20 licensed patents, and 1 national Class I new drug certificate.

The hospital's revenue model is multi-stream: medical service fees from outpatient/inpatient care, national research grants (National Key R&D Program, NSFC, 863 Program), GCP-certified clinical trial revenue, physician continuing-education program fees (6-12 month进修 training priced 6,000-10,000 CNY), and an emerging digital care stream via its 2025 Internet Hospital platform and patient-facing APP. Customer segments include individual oncology patients across China, training physicians from regional hospitals, clinical trial subjects, and Medical Alliance partner institutions in Yunnan and Inner Mongolia. The hospital also operates a public-facing science education mini-program (北肿微课堂) with 600+ original health videos distributed through WeChat.

Name

北京大学肿瘤医院

Legal name

北京大学肿瘤医院

Website

https://bjcancer.org

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

51–100 employees

Short description

Peking University Cancer Hospital is a National Class III Grade A state-owned cancer specialty hospital affiliated with Peking University, delivering end-to-end oncology care, translational research, and graduate medical education through multi-specialty centers and an expanding Internet Hospital platform.

Ownership category

akta.pro rank

Product category

Specialty Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG), Gastrointestinal Oncology (HLAKAFAK), Thoracic (Lung) Oncology (HLAKAFAL)

Keywords

• Oncology specialty hospital
• Cancer diagnosis and treatment
• Molecular diagnostics services
• Clinical oncology training
• Cancer clinical trials

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. 医疗服务收入: 医院作为三级甲等肿瘤专科医院，通过提供门诊、住院、手术、检查、治疗等医疗服务收取费用。主要服务包括：胃肠肿瘤中心、胸部肿瘤中心、乳腺癌预防治疗中心、分子诊断中心等特色专科服务。
2. 教育培训收入: 医院开展进修培训项目收取费用。长期进修6个月6000-8000元、12个月8000-10000元；短期进修3个月5000元；另提供国家卫健委人才交流服务中心培训项目。
3. 临床试验收入: 医院设有I期临床病区，开展抗肿瘤新药临床试验，产生研究收入。科室拥有国家药物临床试验机构（GCP）资质。
4. 科研项目收入: 医院承担国家重点研发计划、国家自然科学基金、863计划、科技创新2030重大专项等国家级科研项目获得经费支持。

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Peking University Cancer Hospital delivers comprehensive oncology services across prevention, screening, diagnosis, treatment, and rehabilitation through specialized centers covering gastrointestinal cancer, thoracic oncology, breast cancer, soft tissue and retroperitoneal tumors, and molecular diagnostics. The hospital integrates multidisciplinary treatment (MDT), precision medicine, surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy, and clinical trials, supported by national key laboratories and translational research programs. It also offers graduate medical education, clinical training programs, and an Internet Hospital platform for remote consultations and follow-ups.

Product overview

北京大学肿瘤医院 operates as a Class A tertiary cancer specialty hospital (国家三级甲等肿瘤专科医院) offering a comprehensive, multi-disciplinary oncology service portfolio. The hospital's core clinical services are organized into specialized tumor centers including the Gastrointestinal Cancer Center (胃肠肿瘤中心), Thoracic Oncology Center (胸部肿瘤中心), Breast Cancer Prevention and Treatment Center (乳腺癌预防治疗中心), Soft Tissue and Retroperitoneal Tumor Center (软组织与腹膜后肿瘤中心), and Molecular Diagnostics Center (分子诊断中心). These centers provide surgical, medical, and radiation oncology care integrated through a Multi-Disciplinary Treatment (MDT) model. Patient-facing digital services include the 北大肿瘤医院APP (for appointment booking, online consultations, and inpatient management), the 互联网医院 (Internet Hospital) platform for video visits and e-prescriptions, and the 北肿微课堂 science education platform with 600+ videos. The hospital also operates a Teaching Information Service Platform (教学信息服务平台) for graduate medical education and clinical training. Research is supported by multiple basic science laboratories (胃肠肿瘤转化研究实验室, 细胞生物学研究室, 分子肿瘤学研究室, 病因学研究室) focusing on cancer etiology, molecular biology, and translational research. The hospital is affiliated with Peking University and includes the Beijing Institute for Cancer Prevention and Control.

Differentiator

Problem solved

Functional benefit

Brands

• 北大肿瘤医院APP: Mobile application for patient appointment booking, medical services, and health information
• 北肿微课堂

Products and services

• 胃肠肿瘤中心 (Gastrointestinal Cancer Center) Specialized digestive tumor diagnosis and treatment center covering gastric cancer, colorectal cancer, and other gastrointestinal malignancies. The center consists of four inpatient wards and integrates surgical, medical, and multidisciplinary approaches for comprehensive GI cancer care.
• 胸部肿瘤中心 (Thoracic Oncology Center) Specialized thoracic tumor diagnosis and treatment center covering lung cancer, esophageal cancer, and mediastinal tumors, including Thoracic Surgery Departments 1 and 2, Thoracic Oncology Departments 1 and 2, and Radiation Oncology.
• 乳腺癌预防治疗中心 (Breast Cancer Prevention and Treatment Center) Breast cancer prevention and treatment center providing comprehensive services including early screening, surgical treatment, medical oncology, and rehabilitation for breast cancer patients.
• 软组织与腹膜后肿瘤中心 (Soft Tissue and Retroperitoneal Tumor Center) Specialized center for soft tissue and retroperitoneal tumors offering surgical treatment, comprehensive therapy, and international academic exchange for sarcomas and retroperitoneal malignancies. Recognized as Asia's largest and internationally renowned melanoma and sarcoma treatment center, with annual outpatient volume exceeding 30,000 visits and over 8,000 inpatients treated.
• 分子诊断中心 (Molecular Diagnostics Center) Molecular diagnostics center using high-throughput sequencing and molecular diagnostic technologies to provide tumor genetic testing services for molecular classification, treatment decisions, and prognostic evaluation.
• 多学科诊疗 (MDT) Multi-disciplinary tumor diagnosis and treatment model that integrates surgical oncology, medical oncology, radiation oncology, imaging, pathology, and other specialists to develop personalized treatment plans for complex cancer cases.
• 互联网医院 (Internet Hospital) Online hospital platform enabling video consultations, e-prescriptions, examination ordering, and remote medical services for follow-up patients, accessible via the 北大肿瘤医院APP. Launched in 2025.
• 教学信息服务平台 (Teaching Information Service Platform) Educational information service platform (teach.bjcancer.org) providing graduate medical education, clinical training programs, visiting scholar applications, academic conferences, and student management for medical professionals. Includes long-term进修 (6-12 months), short-term进修 (3 months), specialized training, and graduate research training.
• 临床试验招募 (Clinical Trial Recruitment) Clinical trial recruitment service for cancer patients, offering access to investigational new drugs and novel treatment modalities under the hospital's GCP-certified clinical trial institution.

Quantifiable outcome

• 黑色素瘤与肉瘤内科年门诊量逾3万人次，收治患者超8000例
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability7 records

Feature9 records

Partnerships

Eight partnerships are on record, tiered 核心 and 重要.

• 北京大学核心Strategic or Co-development Partner北京大学肿瘤医院是北京大学的附属医院，依托北京大学的教学和科研资源开展医教研全方位合作。医院是北京大学临床医学和基础医学国家双一流建设学科单位。
• 北京大学医学部核心Strategic or Co-development Partner医院隶属于北京大学医学部，开展研究生培养、住院医师规范化培训、继续医学教育等合作。
• 浙江大学重要Strategic or Co-development Partner浙江大学师生赴北京大学肿瘤医院开展共建交流活动，双方在科研项目、联合实验室和人才交流等方面开展合作。医学创新日益依赖临床医学与化学、材料、工程及信息科学等学科的协同。
• 北京大学肿瘤医院云南医院重要Strategic or Co-development Partner医院派出专家团队支持云南医院建设，云南医院第六批派驻专家欢迎座谈会已召开。
• 北京大学肿瘤医院内蒙古医院重要Strategic or Co-development Partner医院与内蒙古医院开展合作，内蒙古医院副院长冯立出席笃行杯博士生学术论坛。
• 石河子大学第一附属医院重要Strategic or Co-development Partner石河子大学第一附属医院副院长王丽出席活动，双方开展人才培养和学术交流合作。
• 北大药学院、基础医学院、计算机学院核心Strategic or Co-development Partner胃肠肿瘤转化研究实验室与北大药学院、基础医学院、计算机学院等基础学科交叉融合，协同创新，在胃癌微环境解析及调控机制、药敏模型搭建、新治疗靶点开发及人工智能预测模型开发等方面发表了系列合作成果。
• 国家卫生健康委人才交流服务中心重要Implementation/ SI/ Consulting Partner医院成为国家卫生健康委人才交流服务中心放疗、消化内镜项目培训单位，开展临床医师培训合作。

Scale indicators18 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Peking University First Hospital: General tertiary Class A hospital under the same parent (Peking University). Comparable as a sister institution within the Peking University medical system, though not a cancer specialty provider.
• Memorial Sloan Kettering Cancer Center: Premier U.S. academic cancer hospital. Comparable as a leading specialty oncology institution with world-class research output, clinical innovation, and multidisciplinary care models.
• MD Anderson Cancer Center: Global-leading academic cancer center in the United States. Comparable as a top-tier oncology institution with deep translational research capabilities, though operating under a different healthcare system and at substantially larger scale.

Direct peers

• Zhejiang Cancer Hospital: Provincial tertiary cancer specialty hospital in eastern China. Directly comparable as a regional cancer center with strong clinical research programs and academic affiliations.
• National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences: The national-level cancer center of China, operated by CAMS/PUMC. Directly comparable as the flagship national cancer hospital with the most comprehensive oncology research and treatment capabilities in the country.
• Fudan University Shanghai Cancer Center: Top-tier tertiary Class A cancer specialty hospital affiliated with Fudan University. Directly comparable in scale, national designation, research output, and multi-disciplinary oncology services to Peking University Cancer Hospital.
• Sun Yat-sen University Cancer Center: Leading tertiary cancer specialty hospital in southern China affiliated with Sun Yat-sen University. Comparable as a top-tier academic cancer center with strong translational research and multi-disciplinary treatment capabilities.
• Tianjin Medical University Cancer Institute and Hospital: Major tertiary cancer specialty hospital in northern China affiliated with Tianjin Medical University. Comparable scale and clinical/research profile to Peking University Cancer Hospital with strong translational oncology programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xweibo.com/bjcancer
• LinkedInlinkedin.com/company/%E5%8C%97%E4%BA%AC%E5%A4%A7%E5%AD%A6%E8%82%BF%E7%98%A4%E5%8C%BB%E9%99%A2

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 北京大学肿瘤医院